RC848.C5 M36 2012eb
|
Managing the complications of cirrhosis : a practical approach / |
1 |
RC848.C5 V37 2021
|
Variceal bleeding in liver cirrhosis / |
1 |
RC848.F27 C37 2011eb
|
Cardiovascular diseases and liver transplantation / |
1 |
RC848.F27 L58 2020
|
Liver failure : acute and acute on chronic / |
1 |
RC848.F29
|
Fasciolosis : causes, challenges and controls / |
1 |
RC848.F3
|
Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) / Nonalcoholic fatty liver disease (NAFLD) / |
2 |
RC848.F3 B37 2009eb
|
Pathophysiology of nonalcoholic steatohepatitis / |
1 |
RC848.F3 E87 2023
|
Essentials of non-alcoholic fatty liver disease : complications and extrahepatic manifestations / |
1 |
RC848.F3 N66 2013eb
|
Non-alcoholic fatty liver disease : a practical guide / |
1 |
RC848.F3 N66 2020
|
Non-alcoholic fatty liver disease : a 360-degree overview / |
1 |
RC848.H38
|
Helminth infections and their impact on global public health / |
1 |
RC848.H42 A26 2002eb
|
Understanding hepatitis / |
1 |
RC848.H425
|
Hepatitis C infection in dialysis / Hepatitis C : epidemiology, prevention and elimination. Hepatitis C. |
3 |
RC848.H425 A38 2012eb
|
Advanced therapy for hepatitis C / |
1 |
RC848.H425 F45 2002eb
|
Hepatitis C virus : from laboratory to clinic / |
1 |
RC848.H425 F73 2011eb
|
Making disease, making citizens : the politics of hepatitis C / |
1 |
RC848.H43
|
Viral hepatitis / Clinical dilemmas in viral liver disease / |
2 |
RC848.H43 C65 2010eb
|
Clinical dilemmas in viral liver disease / |
1 |
RC848.H44
|
Eliminating the public health problem of hepatitis B and C in the United States : phase one report / Hepatitis B virus infection : molecular virology to antiviral drugs / Hepatitis B virus and liver disease / |
3 |
RC848.H44 .P36 2021
|
Protocol to Estimate Mortality from Cirrhosis and Hepatocellular Carcinoma Attributable to Viral Hepatitis B and C |
1 |